Clonazepam-induced misidentification in prodromal dementia with Lewy bodies

Psychogeriatrics. 2022 Sep;22(5):767-769. doi: 10.1111/psyg.12873. Epub 2022 Jul 9.

Authors

Daichi Morioka¹, Ryota Kobayashi¹, Hiroshi Hayashi², Shinobu Kawakatsu³, Akihito Suzuki¹

Affiliations

¹ Department of Psychiatry, Yamagata University School of Medicine, Yamagata, Japan.
² Department of Occupational Therapy, Fukushima Medical University School of Health Sciences, Fukushima, Japan.
³ Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu, Japan.

PMID: 35808967
DOI: 10.1111/psyg.12873

No abstract available

Keywords: Capgras syndrome; clonazepam; dementia with Lewy bodies; misidentification.

MeSH terms

Clonazepam / therapeutic use
Humans
Lewy Bodies
Lewy Body Disease* / diagnosis
Lewy Body Disease* / drug therapy
Prodromal Symptoms

Substances

Clonazepam

Grants and funding

16K09228/The Japanese Ministry of Education, Culture, Sports, Science and Technology